Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 28302 | 210 | 35.7 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 103 | 3 | O GLCNACYLATION//O GLCNAC TRANSFERASE//O GLCNACASE | 73436 |
| 2562 | 2 | GALECTIN//GALECTIN 3//GALECTIN 1 | 3715 |
| 28302 | 1 | GALECTIN 3//EMERGING BIOMARKERS//FOOD HYG EPIDEMIOL | 210 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | GALECTIN 3 | authKW | 1970043 | 52% | 12% | 110 |
| 2 | EMERGING BIOMARKERS | authKW | 290813 | 1% | 100% | 2 |
| 3 | FOOD HYG EPIDEMIOL | address | 290813 | 1% | 100% | 2 |
| 4 | BAYLOR JACK JANE HAMILTON HEART VASC HOSITAL | address | 145407 | 0% | 100% | 1 |
| 5 | C TERMINAL PROPEPTIDE OF TYPE I PROCOLLAGEN | authKW | 145407 | 0% | 100% | 1 |
| 6 | CARBOHYDRATE AND PURINE METABOLISM | authKW | 145407 | 0% | 100% | 1 |
| 7 | CARDIOL UMR S 942 | address | 145407 | 0% | 100% | 1 |
| 8 | CLIN IPERTENS ARTERIOSA UOSD | address | 145407 | 0% | 100% | 1 |
| 9 | EQUIPEOBES INSUFFISANCE CARDIAQUE PROCHE MOL | address | 145407 | 0% | 100% | 1 |
| 10 | FAILURE WITH PRESERVED EJECTION FRACTION | authKW | 145407 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 4360 | 56% | 0% | 118 |
| 2 | Medical Laboratory Technology | 1327 | 13% | 0% | 28 |
| 3 | Peripheral Vascular Diseases | 193 | 10% | 0% | 20 |
| 4 | Medicine, Research & Experimental | 55 | 7% | 0% | 15 |
| 5 | Pathology | 26 | 4% | 0% | 8 |
| 6 | Transplantation | 5 | 1% | 0% | 3 |
| 7 | Medicine, General & Internal | 4 | 4% | 0% | 8 |
| 8 | Biotechnology & Applied Microbiology | 4 | 3% | 0% | 7 |
| 9 | Geriatrics & Gerontology | 3 | 1% | 0% | 2 |
| 10 | Urology & Nephrology | 3 | 2% | 0% | 4 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | FOOD HYG EPIDEMIOL | 290813 | 1% | 100% | 2 |
| 2 | BAYLOR JACK JANE HAMILTON HEART VASC HOSITAL | 145407 | 0% | 100% | 1 |
| 3 | CARDIOL UMR S 942 | 145407 | 0% | 100% | 1 |
| 4 | CLIN IPERTENS ARTERIOSA UOSD | 145407 | 0% | 100% | 1 |
| 5 | EQUIPEOBES INSUFFISANCE CARDIAQUE PROCHE MOL | 145407 | 0% | 100% | 1 |
| 6 | GOTTINGEN CARDIOL | 145407 | 0% | 100% | 1 |
| 7 | HERZ DIADETESZENTRUM NRW | 145407 | 0% | 100% | 1 |
| 8 | INSERM UMR TEAM 1 872 | 145407 | 0% | 100% | 1 |
| 9 | INTERNAL MEDHEART FAILURE CARDI | 145407 | 0% | 100% | 1 |
| 10 | INVEST CLIN PLURITHEMAT 1433UMR 1116 | 145407 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JACC-HEART FAILURE | 12230 | 2% | 2% | 5 |
| 2 | EUROPEAN JOURNAL OF HEART FAILURE | 10418 | 6% | 1% | 13 |
| 3 | JOURNAL OF THE AMERICAN HEART ASSOCIATION | 4143 | 3% | 0% | 7 |
| 4 | CIRCULATION-HEART FAILURE | 2691 | 2% | 0% | 4 |
| 5 | JOURNAL OF CARDIAC FAILURE | 2118 | 2% | 0% | 5 |
| 6 | BIOMARKERS IN MEDICINE | 1888 | 1% | 0% | 3 |
| 7 | REVIEWS IN CARDIOVASCULAR MEDICINE | 1775 | 1% | 1% | 2 |
| 8 | CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 1694 | 3% | 0% | 7 |
| 9 | MINERVA CARDIOANGIOLOGICA | 1330 | 1% | 0% | 2 |
| 10 | SETAC SPECIAL PUBLICATIONS SERIES | 1080 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | LEONE, M , IACOVIELLO, M , (2016) THE PREDICTIVE VALUE OF PLASMA BIOMARKERS IN DISCHARGED HEART FAILURE PATIENTS: ROLE OF GALECTIN-3.MINERVA CARDIOANGIOLOGICA. VOL. 64. ISSUE 2. P. 181 -194 | 39 | 80% | 3 |
| 2 | FILIPE, MD , MEIJERS, WC , VAN DER VELDE, AR , DE BOER, RA , (2015) GALECTIN-3 AND HEART FAILURE: PROGNOSIS, PREDICTION & CLINICAL UTILITY.CLINICA CHIMICA ACTA. VOL. 443. ISSUE . P. 48 -56 | 41 | 57% | 10 |
| 3 | CARRASCO-SANCHEZ, FJ , PAEZ-RUBIO, MI , (2014) REVIEW OF THE PROGNOSTIC VALUE OF GALECTIN-3 IN HEART FAILURE FOCUSING ON CLINICAL UTILITY OF REPEATED TESTING.MOLECULAR DIAGNOSIS & THERAPY. VOL. 18. ISSUE 6. P. 599 -604 | 27 | 87% | 3 |
| 4 | SRIVATSAN, V , GEORGE, M , SHANMUGAM, E , (2015) UTILITY OF GALECTIN-3 AS A PROGNOSTIC BIOMARKER IN HEART FAILURE: WHERE DO WE STAND?.EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. VOL. 22. ISSUE 9. P. 1096 -1110 | 28 | 72% | 6 |
| 5 | ABOUEZZEDDINE, OF , HAINES, P , STEVENS, S , NATIVI-NICOLAU, J , FELKER, GM , BORLAUG, BA , CHEN, HH , TRACY, RP , BRAUNWALD, E , REDFIELD, MM , (2015) GALECTIN-3 IN HEART FAILURE WITH PRESERVED EJECTION FRACTION A RELAX TRIAL SUBSTUDY (PHOSPHODIESTERASE-5 INHIBITION TO IMPROVE CLINICAL STATUS AND EXERCISE CAPACITY IN DIASTOLIC HEART FAILURE).JACC-HEART FAILURE. VOL. 3. ISSUE 3. P. 245 -252 | 20 | 71% | 18 |
| 6 | CHEN, YS , GI, WT , LIAO, TY , LEE, MTG , LEE, SH , HSU, WT , CHANG, SS , LEE, CC , (2016) USING THE GALECTIN-3 TEST TO PREDICT MORTALITY IN HEART FAILURE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.BIOMARKERS IN MEDICINE. VOL. 10. ISSUE 3. P. 329 -342 | 28 | 53% | 1 |
| 7 | VAN DER VELDE, AR , MEIJERS, WC , HO, JE , BROUWERS, FP , RIENSTRA, M , BAKKER, SJL , KOBOLD, ACM , VAN VELDHUISEN, DJ , VAN GILST, WH , VAN DER HARST, P , ET AL (2016) SERIAL GALECTIN-3 AND FUTURE CARDIOVASCULAR DISEASE IN THE GENERAL POPULATION.HEART. VOL. 102. ISSUE 14. P. 1134 -1141 | 20 | 71% | 1 |
| 8 | EDELMANN, F , HOLZENDORF, V , WACHTER, R , NOLTE, K , SCHMIDT, AG , KRAIGHER-KRAINER, E , DUVINAGE, A , UNKELBACH, I , DUNGEN, HD , TSCHOPE, C , ET AL (2015) GALECTIN-3 IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS FROM THE ALDO-DHF TRIAL.EUROPEAN JOURNAL OF HEART FAILURE. VOL. 17. ISSUE 2. P. 214 -223 | 17 | 65% | 21 |
| 9 | IMRAN, TF , SHIN, HJ , MATHENGE, N , WANG, F , KIM, B , JOSEPH, J , GAZIANO, JM , DJOUSSE, L , (2017) META-ANALYSIS OF THE USEFULNESS OF PLASMA GALECTIN-3 TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH HEART FAILURE AND IN THE GENERAL POPULATION.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 119. ISSUE 1. P. 57 -64 | 18 | 78% | 0 |
| 10 | BELTRAMI, M , RUOCCO, G , DASTIDAR, AG , FRANCI, B , LUCANI, B , ALOIA, E , NUTI, R , PALAZZUOLI, A , (2016) ADDITIONAL VALUE OF GALECTIN-3 TO BNP IN ACUTE HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION.CLINICA CHIMICA ACTA. VOL. 457. ISSUE . P. 99 -105 | 21 | 66% | 0 |
Classes with closest relation at Level 1 |